As we continue to focus on the US market with our direct sales efforts we are pleased that our Australian partner INBIO has agreed to take on majority ownership of the KK, including financial and operational responsibilities. The experience of INBIO executives in the Japanese markets as well as their proximity will enable more efficient management of our now jointly owned Japanese subsidiary.

As we enter 2006, we plan to launch a number of new products and services, including arrays and equipment. These products and services will address established markets as well as emerging markets including molecular diagnostics and defense applications.